Recent Finacing
Recent Raise
OxThera is a Stockholm biopharmaceutical developing Oxabact (oral freeze‑dried Oxalobacter formigenes) and Oxazyme (oxalate decarboxylase) to promote intestinal oxalate elimination for primary and secondary hyperoxaluria.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
